name:-0.08618688583374
name:-0.05682110786438
name:-0.027386903762817
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED Patent Filings

SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED

Patent Applications and Registrations

Patent applications and USPTO patent grants for SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED.The latest application filed is for "treatment for parkinson's disease".

Company Profile
39.75.113
  • SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED - Maharashtra IN
  • SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - Mumbai IN
  • SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED - Mumbai, Maharashtra IN
  • Sun Pharma Advanced Research Company Ltd - Mumbai IN
  • SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED - Mumbai IN
  • SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED - Andheri (East), Mumbai IN
  • SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - Mumbai, Maharashtra N/A IN
  • Sun Pharma Advanced Research Company Ltd. - Andheri E
  • Sun Pharma Advanced Research Company Limited - Andheri (e) Mumbai N/A IN
  • SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - Andheri (East), Mumbai IN
  • SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - Andheri East
  • Sun Pharma Advanced Research Company Ltd. - IN IN
  • SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - MUMBAI, STATE OF MAHARASHTRA IN
  • Sun Pharma Advanced Research Company Ltd. - Andheri (E), Mumbai IN
  • Sun Pharma Advanced Research Company Ltd. - Andheri IN
  • Sun Pharma Advanced Research Company Ltd - Andheri East
  • SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED - Baroda IN
  • Sun Pharma Advanced Research Company Limited - Gujarat IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Abuse deterrent oral solid dosage form
Grant 11,439,600 - Dharmadhikari , et al. September 13, 2
2022-09-13
Treatment For Parkinson's Disease
App 20220273632 - DAMLE; Nitin Krishnaji ;   et al.
2022-09-01
Treatment For Synucleinopathies
App 20220257582 - DAMLE; Nitin Krishnaji ;   et al.
2022-08-18
Camptothecin Derivatives
App 20220242874 - PATEL; Jiten Ranchhodbhai ;   et al.
2022-08-04
Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide
Grant 11,351,123 - Zala , et al. June 7, 2
2022-06-07
Malic Enzyme Inhibitors
App 20220127266 - Sheth; Gaurav Sanjivkumar ;   et al.
2022-04-28
Method of treating carcinoma
Grant 11,304,898 - Ma , et al. April 19, 2
2022-04-19
Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[N'-(2-chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide
Grant 11,273,126 - Zala , et al. March 15, 2
2022-03-15
Ophthalmic solution of bimatoprost
Grant 11,241,443 - Khopade , et al. February 8, 2
2022-02-08
Malic enzyme inhibitors
Grant 11,225,480 - Sheth , et al. January 18, 2
2022-01-18
Ophthalmic Solution Of Difluprednate
App 20210353540 - Khopade; Ajay Jaysingh ;   et al.
2021-11-18
Method Of Increasing Bioavailability And/or Prolonging Ophthalmic Action Of A Drug
App 20210308130 - Khopade; Ajay Jaysingh ;   et al.
2021-10-07
Novel Amorphous Dispersion Of 4-methyl-3-quinolin-3-ylethynyl-benzoic Acid N'-(2-chloro-6-methyl-benzoyl) Hydrazide
App 20210267906 - ZALA; Yashoraj ;   et al.
2021-09-02
Ophthalmic solution of difluprednate
Grant 11,103,451 - Khopade , et al. August 31, 2
2021-08-31
An Injection Device
App 20210260300 - PATIL; Satyashodhan ;   et al.
2021-08-26
Selective Estrogen Receptor Degrader
App 20210261534 - PAL; Ranjan Kumar ;   et al.
2021-08-26
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
Grant 11,058,684 - Khopade , et al. July 13, 2
2021-07-13
Selective estrogen receptor degrader
Grant 11,014,915 - Pal , et al. May 25, 2
2021-05-25
Stable Multiparticulate Pharmaceutical Composition Of Rosuvastatin
App 20210137921 - DHARMADIKARI; Nitin Bhalachandra ;   et al.
2021-05-13
Ophthalmic solution of difluprednate
Grant 11,000,475 - Khopade , et al. May 11, 2
2021-05-11
Malic Enzyme Inhibitors
App 20210115038 - Sheth; Gaurav Sanjivkumar ;   et al.
2021-04-22
Novel Amorphous Dispersion Of Cyclopropanecarboxylic Acid (5-{5-[n'-(2-chloro-6-methylbenzoyl) Hydrazinocarbonyl] -2-methyl-phenylethynyl}-pyridin-2-yl) Amide
App 20210113470 - ZALA; Yashoraj ;   et al.
2021-04-22
Novel Heterocyclic Antiestrogens
App 20210053947 - PAL; Rajan Kumar ;   et al.
2021-02-25
Selective Estrogen Receptor Degrader
App 20210024504 - PAL; Rajan Kumar ;   et al.
2021-01-28
Treatment For Parkinson's Disease
App 20210015805 - DAMLE; Nitin Krishnaji ;   et al.
2021-01-21
Heterocyclic antiestrogens
Grant 10,865,199 - Pal , et al. December 15, 2
2020-12-15
Treatment of Parkinson's disease
Grant 10,849,887 - Damle , et al. December 1, 2
2020-12-01
Abuse Deterrent Oral Solid Dosage Form
App 20200222329 - DHARMADHIKARI; Nitin ;   et al.
2020-07-16
Drug Loaded Nanoresin Particles
App 20200170951 - Khopade; Ajay Jaysingh ;   et al.
2020-06-04
Novel Amorphous Dispersion Of 4-methyl-3-quinolin-3-ylethynyl-benzoic Acid N'-(2-chloro-6-methyl-benzoyl) Hydrazide
App 20200085751 - ZALA; Yashoraj ;   et al.
2020-03-19
Ophthalmic Solution Of Bimatoprost
App 20200016169 - KHOPADE; Ajay Jaysingh ;   et al.
2020-01-16
Stable Multiparticulate Pharmaceutical Composition Of Rosuvastatin
App 20200000803 - Dharmadikari; Nitin Bhalachandra ;   et al.
2020-01-02
Nanoparticulate composition
Grant 10,512,608 - Bommagani , et al. Dec
2019-12-24
Stable multiparticulate pharmaceutical composition of rosuvastatin
Grant 10,413,543 - Dharmadikari , et al. Sept
2019-09-17
Treatment Of Parkinson's Disease
App 20190275017 - DAMLE; Nitin Krishnaji ;   et al.
2019-09-12
Viscoelastic Gel of Liraglutide Adapted for Once-Weekly or Once Bi-Weekly Administration
App 20190105268 - Khopade; Ajay Jaysingh ;   et al.
2019-04-11
Oral drug delivery system
Grant 10,226,428 - Dharmadhikari , et al.
2019-03-12
Method Of Increasing Bioavailability And/or Prolonging Ophthalmic Action Of A Drug
App 20190070176 - Khopade; Ajay Jaysingh ;   et al.
2019-03-07
Oral drug delivery system
Grant 10,213,387 - Dharmadhikari , et al. Feb
2019-02-26
Crystalline forms of S-[4-(3-fluoro-3-methylbutyryloxy)but-2-ynyl] 6-.alpha.,9-.alpha.-difluoro-17-.alpha.-(furan-2-yl)carbonyloxy-11-.beta.- -hydroxy-16-.alpha.-methyl-3-oxoandrosta-1,4-diene-17-.beta.-carbothioate
Grant 10,179,800 - Patel , et al. Ja
2019-01-15
Drug Loaded Nanoresin Particles
App 20190008772 - Khopade; Ajay Jaysingh ;   et al.
2019-01-10
Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
Grant 10,172,852 - Khopade , et al. J
2019-01-08
Novel Heterocyclic Antiestrogens
App 20180354936 - PAL; Ranjan Kumar ;   et al.
2018-12-13
Amidoheteroaryl aroyl hydrazide ethynes
Grant 10,150,733 - Chokshi , et al. Dec
2018-12-11
Portable device for cutting a capsule
Grant 10,123,943 - Patil , et al. November 13, 2
2018-11-13
Ophthalmic Solution Of Difluprednate
App 20180311159 - Khopade; Ajay Jaysingh ;   et al.
2018-11-01
Ophthalmic Solution Of Difluprednate
App 20180296571 - Khopade; Ajay Jaysingh ;   et al.
2018-10-18
Method Of Preparing Nanoparticulate Topical Composition
App 20180235983 - BOMMAGANI; Madhusudhan ;   et al.
2018-08-23
Long Acting Liraglutide Compositions
App 20180221451 - Khopade; Ajay Jaysingh ;   et al.
2018-08-09
Multiple Pill Abuse-resistant Immediate Release Solid Dosage Form Of Hydrocodone
App 20180200190 - DHARMADHIKARI; Nitin B. ;   et al.
2018-07-19
Long Acting Liraglutide Compositions
App 20180169010 - Khopade; Ajay Jaysingh ;   et al.
2018-06-21
Abuse deterrent immediate release coated reservoir solid dosage form
Grant 9,980,917 - Dharmadhikari , et al. May 29, 2
2018-05-29
Method Of Treating Carcinoma
App 20180140549 - MA; Wen Wee ;   et al.
2018-05-24
Novel Amidoheteroaryl Aroyl Hydrazide Ethynes
App 20180127372 - CHOKSHI; Hemant Ashvinbhai ;   et al.
2018-05-10
Nanoparticulate Composition
App 20180036243 - BOMMAGANI; Madhusudhan ;   et al.
2018-02-08
Crystalline Forms Of S-[4-(3-fluoro-3-methylbutyryloxy)but-2-ynyl] 6-alpha,9-alpha-difluoro-17-alpha-(furan-2-yl)carbonyloxy-11-beta-hydroxy- -16-alpha-methyl-3-oxoandrosta-1,4-diene-17-beta-carbothioate
App 20180016297 - Patel; Jiten Ranchhodbhai ;   et al.
2018-01-18
Portable Device For Cutting A Capsule
App 20170239143 - Patil; Satyashodhan ;   et al.
2017-08-24
Method Of Increasing Bioavailability And/or Prolonging Ophthalmic Action Of A Drug
App 20170239243 - Khopade; Ajay Jaysingh ;   et al.
2017-08-24
Abuse Deterrent Immediate Release Biphasic Matrix Solid Dosage Form
App 20170189339 - DHARMADHIKARI; Nitin Bhalachandra ;   et al.
2017-07-06
Abuse Deterrent Immediate Release Coated Reservoir Solid Dosage Form
App 20170157060 - DHARMADHIKARI; Nitin Bhalachandra ;   et al.
2017-06-08
Abuse deterrent immediate release biphasic matrix solid dosage form
Grant 9,642,811 - Dharmadhikari , et al. May 9, 2
2017-05-09
Ophthalmic composition comprising a prostaglandin
Grant 9,629,852 - Khopade , et al. April 25, 2
2017-04-25
Abuse deterrent immediate release coated reservoir solid dosage form
Grant 9,616,029 - Dharmadhikari , et al. April 11, 2
2017-04-11
Method of treating a disease condition susceptible to baclofen therapy
Grant 9,610,269 - Dharmadhikari , et al. April 4, 2
2017-04-04
Process For The Preparation Of Unilamellar Liposomal Composition
App 20170087089 - Naik; Sachin Pushkarray ;   et al.
2017-03-30
Stable Multiparticulate Pharmaceutical Composition Of Rosuvastatin
App 20170056401 - DHARMADIKARI; Nitin Bhalachandra ;   et al.
2017-03-02
Ophthalmic composition comprising a prostaglandin
Grant 9,539,262 - Khopade , et al. January 10, 2
2017-01-10
Methods for treatment of inflammatory conditions using S-[4-(3-fleuro-3-methylbutyryloxy)but-2-ynyl]6.alpha., 9.alpha.-difluoro-17.alpha.-(furan-2-yl) carbonyloxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxoandrosta-1,4-diene-17.- beta.-carbothioate
Grant 9,458,187 - Patel , et al. October 4, 2
2016-10-04
Gastric retention system
Grant 9,439,851 - Dharmadhkari , et al. September 13, 2
2016-09-13
Methods For Treatment Of Inflammatory Conditions Using S-[4-(3- Fluoro-3-methylbutyryloxy) But-2-ynyl] 6alpha, 9alpha-difluoro-17alpha-(furan-2-yl) Carbonyloxy-11beta -hydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta - Carbothioate
App 20160102117 - Patel; Jiten Ranchhodbhai ;   et al.
2016-04-14
Piperidinyl monocarboxylic acids as S1P1 receptor agonists
Grant 9,266,867 - Capet , et al. February 23, 2
2016-02-23
Abuse Deterrent Immediate Release Coated Reservoir Solid Dosage Form
App 20150320689 - DHARMADHIKARI; Nitin Bhalachandra ;   et al.
2015-11-12
Ophthalmic Composition Comprising A Prostaglandin
App 20150290216 - KHOPADE; Ajay Jaysingh ;   et al.
2015-10-15
Pharmaceutical Composition
App 20150290277 - NAMDEO; Alok B. ;   et al.
2015-10-15
Abuse Deterrent Immediate Release Biphasic Matrix Solid Dosage Form
App 20150272902 - DHARMADHIKARI; Nitin Bhalachandra ;   et al.
2015-10-01
Cysteinyl leukotriene antagonists
Grant 9,102,665 - Rathod , et al. August 11, 2
2015-08-11
Pharmaceutical composition
Grant 9,095,514 - Namdeo , et al. August 4, 2
2015-08-04
Diarylacetylene hydrazide containing tyrosine kinase inhibitors
Grant 9,024,021 - Sengupta , et al. May 5, 2
2015-05-05
Dicarboxylic acid derivatives as S1P1 receptor agonists
Grant 8,809,539 - Capet , et al. August 19, 2
2014-08-19
11.beta.-hydroxyandrosta-4-ene-3-ones
Grant 8,785,425 - Patel , et al. July 22, 2
2014-07-22
Nanodispersion of a drug and process for its preparation
Grant 8,778,364 - Khopade , et al. July 15, 2
2014-07-15
Multi-particulate Pharmaceutical Composition
App 20140178484 - Zala; Yashoraj Rupsinh ;   et al.
2014-06-26
Cysteinyl Leukotriene Antagonists
App 20140155596 - Rathod; Rajendrasinh ;   et al.
2014-06-05
Method Of Treating A Disease Condition Susceptible To Baclofen Therapy
App 20140105973 - DHARMADHIKARI; Nitin Bhalachandra ;   et al.
2014-04-17
Novel Piperidinyl Monocarboxylic Acids As S1p1 Receptor Agonists
App 20140099316 - Capet; Marc ;   et al.
2014-04-10
Nanodispersion
App 20140030352 - KHOPADE; Ajay Jaysingh ;   et al.
2014-01-30
Nanodispersion
Grant 8,586,062 - Khopade , et al. November 19, 2
2013-11-19
Diarylacetylene Hydrazide Containing Tyrosine Kinase Inhibitors
App 20130296557 - Sengupta; Prabal ;   et al.
2013-11-07
Novel Ophthalmic Compositions
App 20130267591 - Khopade; Ajay Jaysingh ;   et al.
2013-10-10
Oral Drug Delivery System
App 20130243856 - Dharmadhikari; Nitin Bhalachandra ;   et al.
2013-09-19
Pharmaceutical composition
Grant 8,535,717 - Zala , et al. September 17, 2
2013-09-17
Inhalation device
Grant 8,499,758 - Bhowmick , et al. August 6, 2
2013-08-06
Oral drug delivery system
Grant 8,470,367 - Bhalachandra Dharmadhikari , et al. June 25, 2
2013-06-25
Pharmaceutical composition
Grant 8,431,156 - Zala , et al. April 30, 2
2013-04-30
Pharmaceutical composition
Grant 8,425,938 - Zala , et al. April 23, 2
2013-04-23
Metered Dose Inhaler
App 20130087142 - Kane; Prashant ;   et al.
2013-04-11
Dry Powder Inhalation Composition
App 20130064870 - Bhowmick; Subhas ;   et al.
2013-03-14
Oral Drug Delivery System
App 20130059004 - Dharmadhikari; Nitin Bhalachandra ;   et al.
2013-03-07
Metered drop bottle for dispensing microliter amounts of a liquid in the form of a drop
Grant 8,328,775 - Gokhale , et al. December 11, 2
2012-12-11
Controlled release coated tablets having prolonged gastric retention
Grant 8,187,633 - Dharmadhikari , et al. May 29, 2
2012-05-29
Nanodispersion Of A Drug And Process For Its Preparation
App 20120087959 - Khopade; Ajay Jaysingh ;   et al.
2012-04-12
Hydrazide containing taxane conjugates
Grant 8,133,888 - Patel , et al. March 13, 2
2012-03-13
Novel Derivatives Of Acyl Cyanopyrrolidines
App 20120040897 - Akolkar; Nakul Pramod ;   et al.
2012-02-16
Pharmaceutical Composition
App 20110275597 - Namdeo; Alok B. ;   et al.
2011-11-10
Spaced Drug Delivery System
App 20110250271 - Shanghvi; Dilip Shantilal ;   et al.
2011-10-13
Gastric retention controlled drug delivery system
Grant 8,012,496 - Dudhara , et al. September 6, 2
2011-09-06
Pharmaceutical Composition
App 20110206767 - ZALA; Yashoraj Rupsinh ;   et al.
2011-08-25
Pharmaceutical Composition
App 20110207794 - ZALA; Yashoraj Rupsinh ;   et al.
2011-08-25
Method Of Treating A Disease Condition Susceptible To Baclofen Therapy
App 20110200671 - DHARMADHIKARI; Nitin Bhalachandra ;   et al.
2011-08-18
Novel Hydrazide Containing Taxane Conjugates
App 20110172226 - Patel; Jiten Ranchhodbhai ;   et al.
2011-07-14
Microparticles
App 20110166101 - Bhowmick; Subhas Balaram ;   et al.
2011-07-07
Spaced drug delivery system
Grant 7,964,216 - Shanghvi , et al. June 21, 2
2011-06-21
Ophthalmic Composition
App 20110003816 - Halder; Arindam ;   et al.
2011-01-06
Gastric Retention Controlled Drug Delivery System
App 20100305208 - DUDHARA; Kamlesh Mahanlal ;   et al.
2010-12-02
Nanodispersion
App 20100297244 - Khopade; Ajay Jaysingh ;   et al.
2010-11-25
Gastric retention controlled drug delivery system
Grant 7,776,345 - Dudhara , et al. August 17, 2
2010-08-17
Inhalation Device
App 20100163042 - Bhowmick; Subhas Balaram ;   et al.
2010-07-01
Novel Prodrugs
App 20100145057 - Thennati; Rajamannar ;   et al.
2010-06-10
Ophthalmic Composition Comprising A Prostaglandin
App 20100137432 - Khopade; Ajay Jaysingh ;   et al.
2010-06-03
Stable polymorphic forms of an anticonvulsant
Grant 7,667,042 - Natarajan , et al. February 23, 2
2010-02-23
Metered Drop Bottle For Dispensing Microliter Amounts Of A Liquid In The Form Of A Drop
App 20100016814 - Gokhale; Satish Madhukar ;   et al.
2010-01-21
Oral Controlled Release Tablet
App 20090208572 - Dharmadhikari; Nitin Bhalachandra ;   et al.
2009-08-20
Sustained Release Pharmaceutical Compositions
App 20090110744 - Khopade; Ajay ;   et al.
2009-04-30
Anal applicator
Grant D587,805 - Gokhale , et al. March 3, 2
2009-03-03
Inhaler
Grant D583,463 - Wood , et al. December 23, 2
2008-12-23
Controlled Release Coated Tablets Having Prolonged Gastric Retention
App 20080241238 - Dharmadhikari; Nitin Bhalachandra ;   et al.
2008-10-02
Inhaler
Grant D577,815 - Gokhale , et al. September 30, 2
2008-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed